|
|
||||||||
PET Center, Groningen University Hospital, Groningen; Groningen University Institute for Drug Exploration, Groningen, The Netherlands
Serotonin-1A (5-hydroxytryptamine-1A [5-HT1A]) receptors have been reported to play an important role in the pathophysiology of a variety of psychiatric and neurodegenerative disorders. Animal experiments have shown that 4-(2'-methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-[18F]fluorobenzamido]ethylpiperazine ([18F]MPPF) may be suitable for 5-HT1A receptor imaging in humans. The aim of this study was to determine if [18F]MPPF can be used for the quantitative analysis of 5-HT1A receptor densities in brain regions of healthy human volunteers. Methods: [15O]H2O perfusion scanning was performed before intravenous injection of [18F]MPPF to obtain anatomic information. Cerebral radioactivity was monitored using a PET camera. Plasma metabolites of [18F]MPPF were determined by high-performance liquid chromatography. Binding potentials were calculated using the metabolite-corrected arterial input function and a linear graphic method (Logan-Patlak analysis). Results: The highest levels of radioactivity were observed in the medial temporal cortex, especially in the hippocampal area. In contrast, the cerebellum and basal ganglia showed low uptake of 18F, in accordance with known 5-HT1A receptor distribution. The calculated binding potentials correlated well with literature values for 5-HT1A receptor densities. The binding potentials for [18F]MPPF were 46 times lower than those that have been reported for [carbonyl-11C]-(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridyl) cyclohexanecarboxamide (WAY 100635), indicating that [18F]MPPF has a lower in vivo affinity for 5-HT1A receptors. Conclusion: These results confirm that [18F]MPPF can be used for the quantitative analysis of 5-HT1A receptor distribution in the living human brain. The rapid dissociation from the receptor makes this ligand a possible candidate to monitor changes in endogenous serotonin levels.
Key Words: human brain serotonin-1A receptors 5-hydroxytryptamine-1A receptors 4-(2'-methoxyphenyl)-1-[2'-(N-2''-pyridinyl)-p-fluorobenzamido]ethylpiperazine
Received Oct. 12, 1999; revision accepted Mar. 28, 2000.
For correspondence or reprints contact: Jan Passchier, PhD, PET Center, Groningen University Hospital, 9700 RB Groningen, The Netherlands.
This article has been cited by other articles:
![]() |
C. A. Shively, D. P. Friedman, H. D. Gage, M. C. Bounds, C. Brown-Proctor, J. B. Blair, J. A. Henderson, M. A. Smith, and N. Buchheimer Behavioral Depression and Positron Emission Tomography-Determined Serotonin 1A Receptor Binding Potential in Cynomolgus Monkeys. Arch Gen Psychiatry, April 1, 2006; 63(4): 396 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riad, L. Zimmer, L. Rbah, K. C. Watkins, M. Hamon, and L. Descarries Acute Treatment with the Antidepressant Fluoxetine Internalizes 5-HT1A Autoreceptors and Reduces the In Vivo Binding of the PET Radioligand [18F]MPPF in the Nucleus Raphe Dorsalis of Rat J. Neurosci., June 9, 2004; 24(23): 5420 - 5426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zimmer, L. Rbah, F. Giacomelli, D. Le Bars, and B. Renaud A Reduced Extracellular Serotonin Level Increases the 5-HT1A PET Ligand 18F-MPPF Binding in the Rat Hippocampus J. Nucl. Med., September 1, 2003; 44(9): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Passchier, A. van Waarde, W. Vaalburg, and A. T.M. Willemsen On the Quantification of [18F]MPPF Binding to 5-HT1A Receptors in the Human Brain J. Nucl. Med., July 1, 2001; 42(7): 1025 - 1031. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |